Treatments for RA have hence dramatically improved. Starting with Disease-Modifying Antirheumatic Drugs (DMARDs), the goal is to target the underlying disease process and prevent joint damage. Biologic agents are another class of drugs specifically designed to target parts of the immune system that fuel inflammation. As Dr Sudipta Mohanty emphasizes that treatment is not a one-size-fits-all approach; it's a tailored suit. Dr. Mohanty advises regular consultations to fine-tune treatment plans as the disease evolves, ensuring that each person with RA can lead the fullest life possible. To get more info visit here #DrSudiptaMohanty